Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shouval

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Clinical Transplantation|July 6, 2004
Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantationZiv Ben-Ari, Yaffa Ashur, Nili Daudi, et al.
Vaccine|February 4, 2006
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccinePamela Rendi-Wagner, Daniel Shouval, Blaise Genton, et al.
Transplantation|July 9, 2004
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up studyOren Shibolet, Eran Elinav, Yaron Ilan, et al.
The Journal of Infectious Diseases|December 26, 2016
Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groupsYosef Manor, Matthew Lewis, Daniela Ram, et al.
Harefuah|January 22, 2013
[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver]Eli Zuckerman, Rifaat Safadi, Ran Oren, et al.
Journal of Hepatology|August 19, 2007
Association between consumption of Herbalife nutritional supplements and acute hepatotoxicityEran Elinav, Galia Pinsker, Rifaat Safadi, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Journal of Hepatology|December 17, 2008
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapyDaniel Shouval, Ching-Lung Lai, Ting-Tsung Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international databaseMatan J Cohen, Izhar Levy, Orly Barak, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Clinical Transplantation|July 6, 2004
Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantationZiv Ben-Ari, Yaffa Ashur, Nili Daudi, et al.
Vaccine|February 4, 2006
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccinePamela Rendi-Wagner, Daniel Shouval, Blaise Genton, et al.
Transplantation|July 9, 2004
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up studyOren Shibolet, Eran Elinav, Yaron Ilan, et al.
The Journal of Infectious Diseases|December 26, 2016
Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groupsYosef Manor, Matthew Lewis, Daniela Ram, et al.
Harefuah|January 22, 2013
[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver]Eli Zuckerman, Rifaat Safadi, Ran Oren, et al.
Journal of Hepatology|August 19, 2007
Association between consumption of Herbalife nutritional supplements and acute hepatotoxicityEran Elinav, Galia Pinsker, Rifaat Safadi, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Journal of Hepatology|December 17, 2008
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapyDaniel Shouval, Ching-Lung Lai, Ting-Tsung Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international databaseMatan J Cohen, Izhar Levy, Orly Barak, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
Pageof 10